Amid Debate, Gene-Based Cancer Test Approved

In the chaotic and rapidly expanding field of “personalized medicine,” dozens of companies aim to create tests that read a disease's biochemical tea leaves and anticipate the course it will take. The predictions, which often rely on gene expression patterns, can have a momentous effect, for example, prompting doctors and patients to eschew chemotherapy when a test suggests that a breast cancer has a low risk of recurring.